Poland· PL-100027088
Glucosum Teva
A glucose product containing glucosum, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Glucose is registered in 2 of 19 countries.
Countries holding a registration under ATC V06DC01 (glucose), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Glucose · ATC V06DC01
2 / 19 countries
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Glucosum
- Manufacturer
- Teva Pharmaceuticals Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- V06DC01
- ATC class
- Glucose
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990249411
- gtin05909990249428
- gtin05900004073893
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for glucose.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Glucose · interactions on record
1 record
- 1 moderate
Most severe, free to view
- Fludeoxyglucose (18F)V09IX04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Glucose in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsGlucose ERC 400 mg/ml, oplossing voor injectieEuro Registratie Collectief B.V.
- CzechiaARDEANUTRISOL G 10%ARDEAPHARMA, a.s., Ševětín
- United KingdomAACE Gluco 40% gelEssential-Healthcare Ltd
- BelgiumBalance 1,5% Glucose 1,25 mmol/l CalciumFresenius Medical Care Deutschland
- SwitzerlandGlucose 5 % B. Braun, InfusionslösungB. Braun Medical AG
- Japanブドウ糖扶桑薬品工業
- SpainAPIROSERUM GLUCOSADO ISOTONICO SOLUCION PARA PERFUSIONFresenius Kabi España, S.A.U.
- FranceGLUCOSE 10 % AGUETTANT, solution pour perfusionAGUETTANT
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Glucose B. Braun, Glucose Fresenius
- Belgium · Glucose Aguettant, Glucose B. Braun
- Bulgaria · Глюкоза Бакстер, Глюкоза Браун
- Cyprus · Dextrose /Demo 20%, Dextrose Demo
- Czechia · Ardeanutrisol G, Glucose Fresenius Kabi
- Germany · Glucose B. Braun, Glucose Laboratoire Aguettant
- Denmark · Glucos B. Braun, Glucos Fresenius Kabi
- Estonia · Glucose B. Braun, Glucose B.Braun
- Spain · Dextrosa Fresenius Kabi, Freeflex Glucosa
- Finland · Glucos B. Braun, Glucos Fresenius Kabi
- France · Glucose Aguettant, Glucose B. Braun
- United Kingdom (Northern Ireland) · Glucose Aguettant, Glucose B. Braun Melsungen
- Greece · Dextrose Cooper, Dextrose Fresenius
- Croatia · Glukoza B. Braun, Glukoza Fresenius Kabi
- Hungary · Glucose B. Braun, Glucosum Pannonpharma
- Ireland · Glucose, Glucose Baxter Holding
- Iceland · Glucos Fresenius Kabi, Glucos Viaflo Baxter
- Italy · Glucorange, Glucosio
- Lithuania · Glucose B. Braun, Glucose B.Braun
- Luxembourg · Glucose, Glucose B. Braun
- Latvia · Glucose B.Braun, Glucose Fresenius
- Malta · Dextrose Vioser, Glucose Baxter Holding
- Netherlands · Glucose, Glucose 5% G/V
- Norway · Glucos B. Braun, Glucos Fresenius Kabi
- Portugal · Glucosada, Glucosada Grifols
- Romania · Dextrose Vioser, Glucose B Braun
- Sweden · Glucos B. Braun, Glucos Fresenius Kabi
- Slovenia · Glukoza Baxter, Glukoza Braun
- Slovakia · Glucose Fresenius Kabi, Glucose Intravenous Infusion B.P. Bieffe
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d4f96cef-5844-46bc-997e-258be9c23e5a GET /v1/drugs/d4f96cef-5844-46bc-997e-258be9c23e5a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "400 mg/ml",
"packaging": "05909990249411 ¦ Rp ¦ 4343\n10 amp. 10 ml\n05909990249428 ¦ Rp ¦ 4344\n50 amp. 10 ml\nRp ¦ Skasowane ¦ 4345\n10 amp. 50 ml\n05900004073893 ¦ Rp ¦ 116251\n50 amp. 10 ml",
"substance": "Glucosum 400 mg",
"common_name": "Glucosum",
"pl_product_id": "100027088",
"pozwolenie_nr": "02494",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about glucose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.